[HTML][HTML] The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS

T McDonnell, C Wincup, I Buchholz, C Pericleous… - Blood reviews, 2020 - Elsevier
Abstract Beta-2-Glycoprotein I (β2GPI) plays a number of essential roles throughout the
body. β2GPI, C-reactive protein and thrombomodulin are the only three proteins that …

The geoepidemiology of the antiphospholipid antibody syndrome

M Biggioggero, PL Meroni - Autoimmunity reviews, 2010 - Elsevier
Antiphospholipid antibodies (aPL) can be detected by functional (lupus anticoagulant)
and/or by solid phase assays (anti-cardiolipin and anti-beta2 glycoprotein I). Although …

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

A Tripodi, PG De Groot, V Pengo - Journal of internal medicine, 2011 - Wiley Online Library
Tripodi A, de Groot PG, Pengo V (IRCCS Cà Granda Ospedale Maggiore Policlinico
Foundation and Università degli Studi di Milano, Milan, Italy; Utrecht University Medical …

Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress–induced cell …

Y Ioannou, JY Zhang, FH Passam… - Blood, The Journal …, 2010 - ashpublications.org
Abstract β2-Glycoprotein I (β2GPI) is an evolutionary conserved, abundant circulating
protein. Although its function remains uncertain, accumulated evidence points toward …

[HTML][HTML] Redox control of β2‐glycoprotein I–von Willebrand factor interaction by thioredoxin‐1

FH Passam, S Rahgozar, M Qi, MJ Raftery… - Journal of thrombosis …, 2010 - Elsevier
Summary Background: β 2‐Glycoprotein I (β 2 GPI) is an abundant plasma protein that is
closely linked to blood clotting, as it interacts with various protein and cellular components of …

[HTML][HTML] Pathophysiological mechanisms in antiphospholipid syndrome

BE Harper, R Wills, SS Pierangeli - International journal of clinical …, 2011 - ncbi.nlm.nih.gov
Antiphospholipid syndrome is a systemic autoimmune disease associated with thrombosis
and recurrent fetal loss in the setting of detectable antiphospholipid (aPL) antibodies. The …

[HTML][HTML] Recent advances in understanding antiphospholipid syndrome

ML Bertolaccini, G Sanna - F1000Research, 2016 - ncbi.nlm.nih.gov
Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic
autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the …

From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome

VX Du, H Kelchtermans, PG de Groot, B de Laat - Thrombosis Research, 2013 - Elsevier
The antiphospholipid syndrome (APS) is diagnosed by the combination of vascular
thrombosis and/or pregnancy morbidity and the detection of antiphospholipid antibodies …

Under crossfire: thromboembolic risk in systemic lupus erythematosus

GA Ramirez, M Efthymiou, DA Isenberg… - Rheumatology, 2019 - academic.oup.com
Cerebral and cardiovascular ischaemic events are frequent complications of SLE and
constitute primary causes of permanent damage. However, the pathogenic determinants of …

Autoimmunity and recurrent pregnancy losses

R Cervera, J Balasch - Clinical reviews in allergy & immunology, 2010 - Springer
The relationship between autoimmunity and reproduction has long been recognized. This
relationship is bidirectional and includes many diverse issues, but in this review article, we …